UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Scientific reports, 2020-02, Vol.10 (1), p.2104-2104, Article 2104

2020

Volltextzugriff (PDF)

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

Bioconjugate chemistry, 2011-07, Vol.22 (7), p.1374-1385

2011

Volltextzugriff (PDF)

The EANM practice guidelines for parathyroid imaging

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2801-2822

2021

Volltextzugriff (PDF)

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

Clinical nuclear medicine, 2022-04, Vol.47 (4), p.305-313

2022

Volltextzugriff (PDF)

The Presence of an Arteria Lusoria Should Be Checked When Reporting 18F-FCH PET/CT Performed to Localize Hyperfunctioning Parathyroid Glands

Clinical nuclear medicine, 2023-11, Vol.48 (11), p.958-959

2023

Volltextzugriff (PDF)

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer

Annals of surgical oncology, 2003-07, Vol.10 (6), p.622-627

2003

Volltextzugriff (PDF)

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

The lancet oncology, 2023-08, Vol.24 (8), p.e331-e343

2023

Volltextzugriff (PDF)

18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center

The quarterly journal of nuclear medicine and molecular imaging, 2023-06, Vol.67 (2), p.96

2023

Volltextzugriff (PDF)

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

The lancet oncology, 2018-10, Vol.19 (10), p.e534-e545

2018

Volltextzugriff (PDF)

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

The Journal of nuclear medicine (1978), 2017-08, Vol.58 (8), p.1230-1235

2017

Volltextzugriff (PDF)

18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study

European journal of nuclear medicine and molecular imaging, 2016-10, Vol.43 (11), p.1995-2004

2016

Volltextzugriff (PDF)

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.807-822

2019

Volltextzugriff (PDF)

An essential practice summary of the new EANM guidelines for parathyroid imaging

The quarterly journal of nuclear medicine and molecular imaging, 2022-06, Vol.66 (2), p.93

2022

Volltextzugriff (PDF)

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

Molecular pharmaceutics, 2017-02, Vol.14 (2), p.406-414

2017

Volltextzugriff (PDF)

Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model

Anticancer research, 2013-08, Vol.33 (8), p.3015-3019

2013

Volltextzugriff (PDF)

18F-Fluorocholine PET/CT of Incidental Male Breast Cancer

Clinical nuclear medicine, 2017-01, Vol.42 (1), p.e56-e57

2017

Volltextzugriff (PDF)

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

European radiology, 2018-08, Vol.28 (8), p.3138-3140

2018

Volltextzugriff (PDF)

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

Molecular imaging and biology, 2019-04, Vol.21 (2), p.297-305

2019

Volltextzugriff (PDF)

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

Nuclear medicine and biology, 2020-05, Vol.84-85, p.88-95

2020

Volltextzugriff (PDF)

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

World journal of surgery, 2020-11, Vol.44 (11), p.3761-3769

2020

Volltextzugriff (PDF)

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

EJNMMI radiopharmacy and chemistry, 2023-10, Vol.8 (1), p.30-30, Article 30

2023

Volltextzugriff (PDF)

Cancer Imaging With Fluorine-18–Labeled Choline Derivatives

Seminars in nuclear medicine, 2007-11, Vol.37 (6), p.420-428

2007

Volltextzugriff (PDF)

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Journal of Nuclear Medicine, 2017-08, Vol.58 (8), p.1230-1235

2017

Volltextzugriff (PDF)

Can Fluorodihydroxyphenylalanine PET Replace Somatostatin Receptor Scintigraphy in Patients with Digestive Endocrine Tumors?

The Journal of nuclear medicine (1978), 2006-09, Vol.47 (9), p.1455-1462

2006

Volltextzugriff (PDF)

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1295-1301

2009

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(91)
Science & Technology
(68)
Life Sciences & Biomedicine
(66)
Female
(51)
Male
(50)
Radiopharmaceuticals
(46)
Fluorodeoxyglucose F18
(45)
Middle Aged
(42)
Aged
(37)
Radiology, Nuclear Medicine & Medical Imaging
(33)
Adult
(31)
Positron-Emission Tomography
(27)
Nuclear Medicine
(25)
Positron-Emission Tomography - Methods
(23)
Oncology
(22)
Tomography
(22)
Imaging
(21)
Life Sciences
(21)
Medicine
(21)
Radiology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

The EANM practice guidelines for parathyroid imaging

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

The Presence of an Arteria Lusoria Should Be Checked When Reporting 18F-FCH PET/CT Performed to Localize Hyperfunctioning Parathyroid Glands

Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

An essential practice summary of the new EANM guidelines for parathyroid imaging

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model

18F-Fluorocholine PET/CT of Incidental Male Breast Cancer

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

Cancer Imaging With Fluorine-18–Labeled Choline Derivatives

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Can Fluorodihydroxyphenylalanine PET Replace Somatostatin Receptor Scintigraphy in Patients with Digestive Endocrine Tumors?

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

Suchergebnisse filtern